Exendin variant and conjugate thereof
US8575097B2 · kind B2 · utility
16Cited by
13References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 23, 2010 |
| Grant date | Nov 5, 2013 |
| Priority date | — |
| Expiry date | Apr 23, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a novel Exendin variant and the Exendin variant conjugate conjugating polymer thereon, the pharmaceutical composition comprising them and use of them for treating diseases such as reducing blood glucose, treating diabetes, especially Type II diabetes. The invention also provides the use of Exendin conjugate for lowering body weight.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.